August 2026– date –
-
Enzene Unveils ‘NeX’ Partnership Model to Globalize Biologics Production via Continuous Manufacturing
PharmaSource India Overview Enzene has launched 'NeX,' an end-to-end partnership model designed to establish regional biopharmaceutical manufacturing capabilities globally. Leveraging its fully connected continuous manufacturing platform... -
Cerebral Organoids Enter Industrial Era: Automation Drives Standardization and High-Throughput Scaling for Neuroscience Innovation
Newfund Capital USA Overview Cerebral organoid production is undergoing a transformative industrialization, driven by automated platforms for iPSC generation, expansion, and differentiation. This technological leap standardizes manufactu... -
Off-the-Shelf Advantage: How Scalable Manufacturing Drives Clinical Success for Combination Cell Therapies
Industry Publication USA Overview A recent industry analysis underscores the critical role of manufacturability and scalability from the earliest stages of development for the clinical success of cell therapies, particularly complex comb... -
Point-of-Care Cell Therapy Manufacturing Surges Forward with Miltenyi Biotec’s CliniMACS Prodigy and Octane Medical’s Cocoon Systems
BioPharm International USA Overview Miltenyi Biotec's CliniMACS Prodigy and Octane Medical Group's Cocoon systems are emerging as pivotal technologies for accelerating point-of-care (PoC) manufacturing in cell therapy. These modular, clo... -
Gene Therapy’s Production Puzzle: Why AAV Outscales Lentiviral Vectors in Large-Scale Manufacturing
Industry Analysis USA Overview A recent analysis comparing AAV and lentiviral vector manufacturing platforms, both produced via transient transfection of HEK293 cells, reveals critical downstream manufacturing distinctions. AAV's stable ... -
Gene Therapy Manufacturing: Viral Vector CDMOs Confront Oversupply Amidst Rapid Expansion
IntuitionLabs USA Overview A recent industry report offers a comparative analysis of the AAV and lentiviral vector CDMO market, revealing trends of consolidation and emerging capacity oversupply. It highlights key players like FUJIFILM D... -
AGC Biologics Commits Half of New Yokohama Biomanufacturing Plant to Major Long-Term Deal
Megaproject Japan Overview AGC Biologics has secured a significant multi-million dollar, long-term commercial manufacturing contract with an undisclosed pharmaceutical firm for its new Yokohama facility, set to open in 2027. This landmar... -
Leading CDMOs Lonza, Samsung Biologics, Charles River Laboratories Spearhead Viral Vector Production, Legend Biotech Drives CAR-T Commercialization
GENE ONLINE|News & Opinion. Blog USA Overview Lonza, Samsung Biologics, and Charles River Laboratories are leading the complex viral vector manufacturing essential for scaling cell and gene therapies (CGTs), while Legend Biotech is drivi... -
Hyroad Energy Deploys Mobile Liquid Hydrogen Fueling Station in Southern California to Support Commercial Hydrogen Trucks
Bulk Transporter USA Overview Hyroad Energy has deployed a mobile liquid hydrogen fueling station in Santa Fe Springs, California, to support the operation of hydrogen-powered commercial trucks. This innovative station integrates a Taylo... -
Intellizence Reports July 2026 Saw Robust Funding Rounds in AI, Robotics, and Cleantech, with Cleantech on Pace to Exceed 2025 Annual Totals
Intellizence USA Overview According to an Intellizence report, July 2026 experienced vibrant billion-dollar funding rounds and growth investments across diverse sectors including AI, robotics, defense tech, energy infrastructure, cyberse...
